OIS’ First International Venue

Why Israel? Did you know Tel Aviv has the highest number of startups per capita in the world? (It also boasts the most GDP investment in R&D…)

Ophthalmology Innovation Summit is proud to announce our first international meeting in the beautiful city of Tel Aviv-Yafo, Israel.

We look forward to uniting corporate, capital and clinical leaders to collaborate on the development and commercialization of innovative drugs, devices and diagnostics to address unmet vision disorders.

With Israel being home to almost 70 active venture capital funds, Tel Aviv is an ideal location for our first international expansion.

For more info or to register, click here.

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

Novartis-Regeneron Dispute Enters a New Phase

Novartis-Regeneron Dispute Enters a New Phase

The Myopia Management Market How Big is Big Web

The Myopia Management Market: ‘How Big is Big?’

Despite Interruption, Pixium Vision Aims to Keep Moving Toward Commercializing Prima System (1)

Despite Interruption, Pixium Vision Aims to Keep Moving Toward Commercializing Prima System

Gyroscope Therapeutics Completes Financing to Advance Gene Therapy Candidate for GA

Gyroscope Therapeutics Completes Financing to Advance Gene Therapy Candidate for GA

Article Graphic for Anterior Clinical Panel Web

Anterior Segment Advances That ‘Won’ 2020 and Those Poised To Disrupt the Future

With $36 Million, Visus Starts Phase II Trial of Presbyopia Drop Brimochol Web

With $36 Million, Visus Starts Phase II Trial of Presbyopia Drop Brimochol

About The Author

OIS Contributor

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

SUBSCRIBE TO OIS WEEKLY

Get our monthly newsletter about the latest in opthalmologic innovation.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

STAY CONNECTED

PODCASTS